EU allocates €3.6 million to Belarus to support the system of drug quality control

| By | Belarus, Drug Quality Control

The European Union shall allocate €3.6 million to Belarus for a project to strengthen the drug quality control. This information was published on the website of the Ministry of Health of Belarus, BelTA.

“The Ministry of Health implements annual action program for Belarus ‘International Accreditation of Testing Laboratories for Medical Products and Support to Healthcare in Belarus (BELMED)’. This is the first national pilot project of the European Union in the field of public health,” informed the Ministry of Health.

The program provides reinforcement of the laboratories technical infrastructure for quality control of medicinal products, including allocation of substantial financial resources for the purchase of equipment, training of personnel and a number of other measures. Completion of the project is planned for August 8, 2018.

Among the important objectives of the program, there is also promoting the integration of regulatory system for medicinal products circulation of Belarus into the European system.

“Active work on preparation of the Pharmaceutical Inspectorate of the Ministry of Health joining the program of cooperation of pharmaceutical inspections is carried out at the moment (PIC/S). Achieving this goal will contribute to the international recognition for national certificates of medicinal products compliance with GMP requirements and increase the export potential of Belarusian manufacturers of medicines, having guaranteed quality, efficacy and safety,” noted the Ministry.